Healthcare provider profile · identity verified

James W Kaehr, MD

Family Practice · LONDON, OH · NPI 1184659708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	743	173
Atorvastatin Calcium	Atorvastatin Calcium	525	142
Levothyroxine Sodium	Levothyroxine Sodium	473	92
Lisinopril	Lisinopril	370	105
Hydrochlorothiazide	Hydrochlorothiazide	325	62
Gabapentin	Gabapentin	306	61
Omeprazole	Omeprazole	274	75
Metoprolol Succinate	Metoprolol Succinate	245	53
Glipizide	Glipizide	238	63
Eliquis	Apixaban	223	37
Losartan Potassium	Losartan Potassium	218	45
Furosemide	Furosemide	208	71
Metoprolol Tartrate	Metoprolol Tartrate	207	59
Pantoprazole Sodium	Pantoprazole Sodium	198	55
Potassium Chloride	Potassium Chloride	193	44
Simvastatin	Simvastatin	192	52
Azithromycin	Azithromycin	187	89
Metformin Hcl	Metformin Hcl	170	47
Famotidine	Famotidine	166	53
Tamsulosin Hcl	Tamsulosin Hcl	151	40
Clopidogrel	Clopidogrel Bisulfate	133	31
Metformin Hcl Er	Metformin Hcl	128	35
Prednisone	Prednisone	123	66
Rosuvastatin Calcium	Rosuvastatin Calcium	123	34
Fenofibrate	Fenofibrate	115	24
Trazodone Hcl	Trazodone Hcl	115	20
Albuterol Sulfate Hfa	Albuterol Sulfate	112	38
Sucralfate	Sucralfate	110	35
Buspirone Hcl	Buspirone Hcl	109	25
Meloxicam	Meloxicam	106	38
Allopurinol	Allopurinol	105	26
Alendronate Sodium	Alendronate Sodium	102	21
Sertraline Hcl	Sertraline Hcl	99	24
Citalopram Hbr	Citalopram Hydrobromide	96	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	95	26
Ezetimibe	Ezetimibe	94	22
Cephalexin	Cephalexin	91	50
Donepezil Hcl	Donepezil Hcl	91	16
Jardiance	Empagliflozin	89	16
Pravastatin Sodium	Pravastatin Sodium	89	22
Escitalopram Oxalate	Escitalopram Oxalate	86	27
Fluticasone Propionate	Fluticasone Propionate	72	24
Montelukast Sodium	Montelukast Sodium	69	18
Warfarin Sodium	Warfarin Sodium	69	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	68	16
Ozempic	Semaglutide	68	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	67	41
Carvedilol	Carvedilol	66	18
Januvia	Sitagliptin Phosphate	65	13
Amoxicillin	Amoxicillin	64	40
Ciprofloxacin Hcl	Ciprofloxacin Hcl	64	42
Atenolol	Atenolol	59	16
Nadolol	Nadolol	59	suppressed
Tizanidine Hcl	Tizanidine Hcl	59	29
Terazosin Hcl	Terazosin Hcl	56	17
Carbidopa-Levodopa	Carbidopa/Levodopa	55	suppressed
Paroxetine Hcl	Paroxetine Hcl	55	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	15
Esomeprazole Magnesium	Esomeprazole Magnesium	54	20
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	52	33
Glipizide Er	Glipizide	51	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	48	11
Synthroid	Levothyroxine Sodium	48	13
Finasteride	Finasteride	46	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	46	18
Pioglitazone Hcl	Pioglitazone Hcl	45	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	44	38
Duloxetine Hcl	Duloxetine Hcl	44	12
Hydroxyzine Hcl	Hydroxyzine Hcl	44	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	12
Ibuprofen	Ibuprofen	43	suppressed
Fluconazole	Fluconazole	42	24
Lorazepam	Lorazepam	41	suppressed
Nystatin	Nystatin	41	17
Meclizine Hcl	Meclizine Hcl	39	23
Glimepiride	Glimepiride	38	suppressed
Mupirocin	Mupirocin	38	24
Spironolactone	Spironolactone	36	suppressed
Tramadol Hcl	Tramadol Hcl	36	suppressed
Memantine Hcl	Memantine Hcl	32	11
Ondansetron Odt	Ondansetron	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	11
Folic Acid	Folic Acid	30	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	29	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Klor-Con M20	Potassium Chloride	29	suppressed
Levofloxacin	Levofloxacin	29	25
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Farxiga	Dapagliflozin Propanediol	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	13
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Rivastigmine	Rivastigmine Tartrate	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Colchicine	Colchicine	23	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	23	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Ranolazine Er	Ranolazine	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Jantoven	Warfarin Sodium	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Ibu	Ibuprofen	18	suppressed
Diazepam	Diazepam	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Valsartan	Valsartan	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Estradiol	Estradiol	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Primidone	Primidone	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Linzess	Linaclotide	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	15	suppressed
Terbinafine Hcl	Terbinafine Hcl	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Topiramate	Topiramate	13	suppressed
Cabergoline	Cabergoline	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error